Streetbeat News

CTCX

Carmell Therapeutics Corporation

https://www.carmellrx.com

Industry

Biotechnology

Carmell Therapeutics Corporation focuses on the development of plasma-based bioactive material (PBM) to stimulate tissue repair or growth after injury, disease, and aging. Its lead product candidate is CT-101 bone healing accelerant for tibia fracture healing, foot/ankle fusion, spinal fusion, dental bone graft substitute, and bone void filler; and tissue healing accelerant for androgenetic alopecia and chronic wound healing. The company was founded in 2008 and is based in Pittsburgh, Pennsylvania.

Open

0.22

Mkt cap

4.4M

Volume

232K

High

0.23

P/E Ratio

0.44

52-wk high

4.31

Low

0.20

Div yield

N/A

52-wk low

0.20

Several health care stocks experienced significant price movements during Friday's intraday session. Notable gainers included Catheter Precision (AMEX:VTAK) with a 142.8% increase, and Tevogen Bio Holdings (NASDAQ:TVGN) with a 49.28% rise. On the losing side, NKGen Biotech (NASDAQ:NKGN) fell by 31.9%, and Orgenesis (NASDAQ:ORGS) declined by 28.05%.

Portfolio Pulse from Benzinga Insights

October 18, 2024 | 4:31 pm

In Friday's pre-market session, several health care stocks experienced significant price movements. Notable gainers included Catheter Precision (AMEX:VTAK) with a 151.9% increase, Akanda (NASDAQ:AKAN) up 71.13%, and Tenon Medical (NASDAQ:TNON) rising 39.06%. On the losing side, Orgenesis (NASDAQ:ORGS) fell 37.9%, Molecular Templates (NASDAQ:MTEM) dropped 30.11%, and NKGen Biotech (NASDAQ:NKGN) decreased by 29.02%.

Portfolio Pulse from Benzinga Insights

October 18, 2024 | 12:09 pm

In Thursday's pre-market session, several healthcare stocks experienced significant movements. Molecular Templates (MTEM) saw a 96.6% increase, while Elevance Health (ELV) dropped by 12.47% following its Q3 earnings report. Other notable gainers include Klotho Neurosciences (KLTO) and Healthcare Triangle (HCTI), while Biodexa Pharmaceuticals (BDRX) and 180 Life Sciences (ATNF) were among the losers.

Portfolio Pulse from Benzinga Insights

October 17, 2024 | 12:10 pm

TSMC shares surged 8.1% in pre-market trading due to better-than-expected Q3 results, with revenue up 39% YoY. Other stocks like Staffing 360 Solutions and Gevo also saw significant pre-market movements.

Portfolio Pulse from Avi Kapoor

October 17, 2024 | 9:39 am

In Wednesday's after-market session, several health care stocks experienced significant price movements. Molecular Templates (MTEM) saw a remarkable increase of 189.2%, while HCW Biologics (HCWB) experienced a notable decline of 14.8%. Other gainers included Klotho Neurosciences (KLTO) and Chromocell Therapeutics (CHRO), while Biodexa Pharmaceuticals (BDRX) and Capricor Therapeutics (CAPR) were among the losers.

Portfolio Pulse from Benzinga Insights

October 16, 2024 | 8:31 pm

The article highlights significant pre-market movements in health care stocks on Wednesday. Notable gainers include Biodexa Pharmaceuticals, Carmell, Tempest Therapeutics, NovoCure, NeuroBo Pharmaceuticals, and Windtree Therapeutics. On the losing side, Novavax, Assembly Biosciences, Dogwood Therapeutics, INVO Bioscience, NewGenIvf Group, and ABVC BioPharma experienced declines.

Portfolio Pulse from Benzinga Insights

October 16, 2024 | 12:10 pm

Carmell Therapeutics' shares rose after the company announced it would not pursue a previously planned securities offering. The SEC did not declare the Registration Statement effective, and no securities were issued or sold.

Portfolio Pulse from Benzinga Newsdesk

October 15, 2024 | 8:39 pm

Carmell Corp has filed a Form RW with the SEC, indicating that it will not pursue a previously planned securities offering. The company confirmed that no securities have been issued or sold, and the registration statement has not been declared effective.

Portfolio Pulse from Benzinga Newsdesk

October 15, 2024 | 8:34 pm

In Tuesday's after-market session, several health care stocks experienced significant price movements. Biodexa Pharmaceuticals saw a remarkable 119% increase, while Petros Pharma, Helius Medical Tech, Vaccinex, Aditxt, and Gain Therapeutics also posted gains. Conversely, NewGenIvf Group, HCW Biologics, Carmell, ABVC BioPharma, Tevogen Bio Holdings, and Lipella Pharmaceuticals experienced declines.

Portfolio Pulse from Benzinga Insights

October 15, 2024 | 8:30 pm

The article reports on the after-market movements of several healthcare stocks. Gritstone Bio, Palatin Techs, GRAIL, Cutera, Oragenics, and Aura Biosciences saw gains, while INVO Bioscience, Dogwood Therapeutics, Inhibikase Therapeutics, Carmell, Sera Prognostics, and Biofrontera experienced losses.

Portfolio Pulse from Benzinga Insights

October 14, 2024 | 8:31 pm

All corporate logos and prices are for illustrative purposes only and are not a recommendation, an offer to sell, or a solicitation of an offer to buy any security.